7/7/2014 9:47:28 AM
La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the “Company” or “La Jolla”), a leader in the development of therapeutics targeting significant unmet life-threatening diseases, today announced the appointment of Robert H. Rosen to the Company’s Board of Directors.
Help employers find you! Check out all the jobs and post your resume.
comments powered by